IGF2 and urinary bladder cancer: Since SOX2 mediates stem cell differentiation and iPSC reprogramming mainly via epigenetic regulation, whereby H3K4me3 marks sites with active gene expression35,36, we examined whether H3K4me3 signal on the IGF2 locus is affected by SOX2 expression in bladder cancer cells.